Positive Studies Push Promising Lilly Treatment Forward

Posted: Updated:
(Image provided by Lilly.) (Image provided by Lilly.)
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced a key potential treatment is moving closer to market. Taltz, which is being tested for use by patients with a type of arthritis that causes inflammation in the spine, has met its targets on two late-stage studies. Lilly says the positive results clear the way for it to submit the ankylosing spondylitis treatment for U.S. regulatory approval later this year.

Vice President of Immunology Development Lotus Mallbris says "many people with AS are either untreated or still searching for an effective treatment. By using ASAS40 as the primary endpoint in our clinical development program, we hope to establish a higher treatment bar for AS patients."

ASAS40 means sufferers that were tested showed at least a 40 percent improvement in disease signs and symptoms. Lilly says those who took Taltz "demonstrated a statistically significant and clinically meaningful improvement" over the course of 16 weeks compared to those using placebo.

You can connect to more about the results by clicking here.

  • Perspectives

    • Seven Steps to Overcome Your Fear of Writing

      "I hate to write!" While that phrase is music to my ears, because it ensures my income will persist, it also saddens me. Far too many people dislike writing, largely because they’re intimidated by the process of knitting words into sentences and sentences into paragraphs. Nearly everyone needs to write from time to time, and the ability to assemble words in a coherent way can impact your success. Whether you have to write reports, proposals, memos, or even emails...
    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Hoosier Companies Among 'Most Admired'

      Two Indiana companies are included in Fortune's 2019 list of the "World's Most Admired Companies." The list was determined by a survey of nearly 4,000 executives, directors and analysts who rated companies in their own industries based on criteria such as investment value, quality of management and ability to attract talent.

    • Books & Brews Acquires Flat12 Bierwerks

      Indianapolis-based Books & Brews has announced its acquisition of Flat12 Bierwerks, also based in Indy. Financial terms of the deal are not being disclosed, however Books & Brews says it will continue to operate Flat12 under the same brand name. The acquisition is a continuation of an existing partnership between the two entities. Books & Brews says Flat12 has been a brewery partner for the past two years, brewing all of B&B's flagship and seasonal beers.

    • Hoosier Companies Among 'Best and Brightest'

      Two Indiana companies are among more than 500 selected by the National Association for Business Resources as the 2018 Best and Brightest Companies to Work For in the Nation. The winners were chosen by an independent research firm from more than 2,400 nominations.

    • Indiana Liquor Group to Buy Save-On Liquor Chain

      Indiana Liquor Group LLC will work with the Indiana Alcohol & Tobacco Commission this week for final approval of its purchase of Save-On Liquor stores. Our partners at The Herald Bulletin report Phillip E. Miller agreed to sell the 31-location package store chain to ILG last month. 

    • Cook: Location, Funding Among Eleven Park Questions

      Several ambitious economic development projects are already taking center stage this year, particularly in central Indiana. Indianapolis-based KSM Location Advisors Chief Executive Officer Tim Cook and President Katie Culp say efforts like Eleven Park, which would include a new stadium for the Indy Eleven soccer team, and a potential casino in downtown Indianapolis are among the key projects being talked about. On the (i) on Economic Development segment on Inside INdiana Business...